Drugs

Safe Use Symposium: A Focus on Reducing Preventable Harm from Drugs in the Outpatient Setting

The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research, Professional Affairs and Stakeholder Engagement Staff (PASES), is hosting a one day public symposium entitled “Safe Use Symposium: A Focus on Reducing Preventable Harm from Drugs in the Outpatient Setting.” The purpose of this symposium is to discuss sources of preventable harm from drugs in the outpatient setting, and to stimulate the exchange of ideas among thought leaders on interventions to reduce preventable harms and how these interventions can be studied.

Date:

June 15, 2017

Time:

8:00 a.m. to 4:00 p.m.

Location:

FDA’s White Oak campus
10903 New Hampshire Avenue
Building 31 (The Great Room C)
Silver Spring, MD 20903.

Registration:

Contact:

Christine Lee, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue., Silver Spring, MD 20993-0002, (240)-402-4228, Email: CDERSafeUseInitiative@fda.hhs.gov

 

Page Last Updated: 07/31/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English